RNA polymerase exists in two forms, and only one of them is technically a holoenzyme. In bacteria, the core enzyme alone can build RNA chains but cannot find the right starting point on DNA. When a small protein called a sigma factor attaches to that core, the complete assembly is called the holoenzyme. So RNA polymerase isn’t always a holoenzyme, but it becomes one when it picks up the component needed to start transcription at a specific gene.
Core Enzyme vs. Holoenzyme
In E. coli, the core RNA polymerase is made of five protein subunits: two copies of alpha, one beta, one beta prime, and one omega. Together they weigh about 379 kilodaltons. This core is catalytically competent, meaning it can stitch nucleotides together into an RNA strand. What it cannot do is locate a promoter, the short DNA sequence that marks where a gene begins.
The holoenzyme forms when a sigma factor binds to the core, bringing the total mass to roughly 449 kilodaltons. Neither piece works properly on its own. The core enzyme reads DNA but can’t find the right starting point, and the sigma factor alone can’t recognize promoters either. Only when they combine does a conformational change occur that allows the complex to latch onto promoter sequences and begin transcription accurately.
What the Sigma Factor Actually Does
The sigma factor acts as a GPS for RNA polymerase. It reads specific DNA sequences upstream of a gene (known as the -10 and -35 elements) and positions the enzyme precisely at the transcription start site. Once positioned, it helps pry open the two DNA strands so the enzyme can begin reading the template and assembling a matching RNA molecule.
Interestingly, sigma doesn’t stick around for the whole job. After the enzyme has synthesized about 12 nucleotides of RNA, that short strand fills an exit channel inside the enzyme and physically pushes part of sigma away from its binding site. This triggers sigma’s release from the complex, freeing the core enzyme to continue on its own through the elongation phase. The released sigma factor is then recycled, ready to pair with another core enzyme for a new round of transcription. This cycle of binding, initiating, and releasing is sometimes called the sigma cycle.
Recent evidence has refined this picture slightly. Rather than popping off all at once, sigma often dissociates gradually as the enzyme moves away from the promoter. During this brief transition, elongation factors begin associating with the enzyme before sigma fully departs, creating a short-lived intermediate complex.
Different Sigma Factors, Different Holoenzymes
E. coli has seven different sigma factors, and each one creates a functionally distinct holoenzyme that recognizes a different set of promoters. The primary sigma factor, sigma-70, handles the vast majority of everyday “housekeeping” transcription. The remaining six direct the enzyme to specialized gene sets:
- Sigma-38 activates during starvation or general stress
- Sigma-32 turns on heat shock genes when temperatures spike
- Sigma-28 controls genes for building flagella
- Sigma-24 responds to damage in the cell envelope or extreme heat
- Sigma-19 handles iron transport genes
- Sigma-54 manages nitrogen metabolism
Because all sigma factors compete for the same binding site on the core enzyme, swapping one sigma for another is a powerful way for bacteria to reprogram their gene expression rapidly. When conditions change, a stress-specific sigma factor can outcompete sigma-70 for available core enzymes, redirecting transcription across the entire genome in a single move.
Does the Term Apply to Eukaryotic Cells?
The holoenzyme concept originated with bacterial RNA polymerase, but researchers also use the term for eukaryotic systems. In yeast and human cells, RNA polymerase II (the enzyme that transcribes protein-coding genes) forms a holoenzyme when it associates with a large complex called the Mediator. Structural studies of the yeast version show that Mediator wraps around the polymerase, making contact at a spot that corresponds to where the alpha subunits sit in the bacterial enzyme.
The eukaryotic holoenzyme serves a similar conceptual purpose: it bridges the gap between the catalytic machinery and the regulatory signals that determine which genes get transcribed. But the details are far more complex. Instead of a single sigma factor, eukaryotic transcription initiation requires a suite of general transcription factors, plus the Mediator complex, plus various coactivators. So while “holoenzyme” is used in both contexts, the eukaryotic version involves a much larger cast of proteins.
Why the Distinction Matters
The difference between core enzyme and holoenzyme isn’t just a naming convention. It reflects a fundamental control point in gene regulation. By keeping the catalytic machinery separate from the targeting component, bacteria gain flexibility. A single core enzyme can be directed to completely different sets of genes depending on which sigma factor is available. Cells don’t need to build a new enzyme for every environmental challenge; they just swap out the guidance system.
This modularity also makes sigma factors attractive drug targets. Because human cells don’t use sigma factors, compounds that block sigma from associating with the core enzyme could potentially shut down bacterial transcription without affecting human RNA polymerases. The structural differences between the bacterial holoenzyme and eukaryotic transcription complexes are large enough to offer that kind of selective targeting.